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Abstract Applications of buthionine sulfoximine (BSO),
an inhibitor of GSH (reduced glutathione), which switches
the cellular glutathione pool towards the oxidized form
GSSG, positively inXuences embryo quality by improving
the structure of the shoot apical meristem and promoting
embryo maturation, both of which improve the post-embry-
onic performance of the embryos. To investigate the mecha-
nisms underlying BSO-mediated improvement in embryo
quality the transcript proWles of developing Brassica napus
microspore-derived embryos cultured in the absence (con-
trol) or presence of BSO were analyzed using a 15,000-ele-
ment B. napus oligo microarray. BSO applications induced
major changes in transcript accumulation patterns, especially
during the late phases of embryogenesis. BSO aVected the
transcription and activities of key enzymes involved in ascor-
bate metabolism, which resulted in major Xuctuations in
cellular ascorbate levels. These changes were related to
morphological characteristics of the embryos and their post-
embryonic performance. BSO applications also activated
many genes controlling meristem formation and function,
including ZWILLE, SHOOTMERISTEMLESS, and ARG-
ONAUTE 1. Increased expression of these genes may con-
tribute to the improved structural quality of the shoot poles
observed in the presence of BSO. Compared to their control
counterparts, middle- and late-stage BSO-treated embryos
also showed increased accumulation of transcripts associated
with the maturation phase of zygotic embryo development,
including genes encoding ABA-responsive proteins and stor-
age- and late-embryogenic abundant (LEA) proteins. Overall
these transcriptional changes support the observation that the
BSO-induced oxidized glutathione redox state allows cul-
tured embryos to reach both morphological and physiological
maturity, which in turn guarantees successful regeneration
and enhanced post-embryonic growth.
Keywords Brassica napus · Buthionine sulfoximine · 
Canola · Meristem · Transcript levels
Abbreviations
ASC Reduced ascorbate
APX Ascorbate peroxidase
BSO Buthionine sulfoximine
DHA Dehydroascorbate
DHAR Dehydroascorbate reductase
GR Glutathione reductase
GSH Reduced glutathione
GSSG Oxidized glutathione
MDEs Microspore-derived embryos
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One of the best examples of cellular totipotency, proposed
by Haberlandt (1902), is the ability of plant cells to gener-
ate embryos in culture. This phenomenon was Wrst reported
in the late 1940s by Levine (1947) using carrot cells, and
subsequently extended to a variety of plant species (see
Dunstan et al. 1995; Thorpe and Stasolla 2001). Despite the
improvement in tissue culture conditions achieved for
many species in the last decades, a recurrent problem
encountered during in vitro embryogenesis is the low con-
version rate of the embryos into seedlings. Attempts to
enhance the regeneration frequency of the embryos have
mainly focused on optimizing the culture environment dur-
ing the early phases of embryo development, with the
assumption that once initiated the embryogenic pathway is
completed successfully. Although often true, this notion
cannot be generalized as cellular and tissue deterioration
leading to embryo abortion have been reported in both
angiosperms (Yeung et al. 1996; Belmonte et al. 2006) and
gymnosperms (Kong and Yeung 1992). Such abnormalities
mainly develop during mid- to late-embryogenesis and spe-
ciWcally aVect the integrity of the shoot apical meristem.
Structural studies have revealed that fully formed shoot
meristems degenerate due to the formation of intercellular
spaces, which lead to separation of the meristematic cells.
This is often followed by the loss of meristematic identity
by the apical cells, which acquire parenchymous features
(reviewed by Yeung and Stasolla 2001). It is therefore
apparent that culture conditions during the advanced phases
of embryo development are not optimal.
In vitro embryogenesis can be achieved through two pro-
cesses: somatic embryogenesis, the formation of embryos
from somatic cells, or gametophytic embryogenesis, the
generation of haploid embryos from cells of the male or
female gametophyte. The latter process is advantageous in
that the endogenous genetic variation can be eYciently
Wxed through the recovery of diploid homozygous plants
following artiWcial chromosome doubling by colchicine
treatment (Yao et al. 1997). In general, the most eYcient
system for gametophytic embryogenesis is androgenesis, in
which immature pollen grains (microspores) are used as the
starting material to generate microspore-derived embryos,
MDEs. Androgenesis has been obtained in a variety of sys-
tems through the development of optimized protocols and
is routinely used as an integrated tool in many breeding
programs. Over the past years the canola Brassica napus
MDE system has received increasing attention as a model
to study embryogenesis in plants for a variety of reasons
(Yeung 2002; Boutilier et al. 2005). First, a large numbers
of synchronized embryos can be rapidly and eYciently pro-
duced. Second, the embryogenic pathway is initiated in the
absence of hormones and a callus phase, thereby allowing
studies from the few-celled embryo stage onward. Third,
the morphogenic events occurring during MDE develop-
ment closely mimic those observed during zygotic embryo-
genesis (Yeung et al. 1996). Finally, the genetic similarities
between Brassica and Arabidopsis can be exploited to
apply the genomic information available in the latter for
improving and understanding the mechanisms regulating
Brassica embryogenesis. Due to these advantages, it is not
surprising that the B. napus MDE culture system has been
extensively utilized to investigate anatomical, physiologi-
cal, and molecular events occurring during embryo devel-
opment in vitro (reviewed in Yeung 2002; Boutilier et al.
2005). Recent transcriptome and proteome analyses have
focused on the molecular events delineating the induction
of microspore embryogenesis, that is the initial transition
from gametophytic to embryonic cell state (Joosen et al.
2007; Malik et al. 2007). Both studies have revealed the
existence of robust markers and pathways associated with
the early phases of embryo development. To date however,
there is no information documenting the molecular path-
ways active during the middle and late phases of MDE
development, when cellular deterioration aVects the integ-
rity of the shoot apical meristems and compromises embryo
regeneration.
Alterations in the cellular redox status have been shown
to control embryo development in several systems (Earn-
shaw and Johnson 1987; Gardiner et al. 1998; Shi et al.
2000; Stasolla et al. 2004a; Belmonte et al. 2006). In recent
studies on B. napus, Belmonte et al. (2006) show that the
endogenous glutathione redox status [deWned as the ratio of
the concentration of the reduced form (GSH) to the concen-
tration of the oxidized plus reduced forms (GSSG + GSH)]
can be easily manipulated in culture through applications of
buthionine sulfoximine (BSO). If applied in the medium
after 7 days of culture, BSO induces an oxidized glutathi-
one environment by inhibiting GSH synthesis (GriYth and
Meister 1979), thereby lowering the cellular GSH/
GSH + GSSG ratio. This metabolic switch improves
embryo quality, as measured by the enhanced conversion
frequency, and induces major structural changes in the
developing embryos (Belmonte et al. 2006). Histological
analyses revealed that compared to their control counter-
parts, BSO-treated embryos form well organized meristems
and accumulate storage products in a similar pattern to that
observed in seed embryos. Such characteristics, which can
be reversed if the glutathione redox status is shifted towards
a reduced state through exogenous applications of GSH, are
also observed when BSO is applied to other plant culture
systems (Belmonte et al. 2007). The enhanced embryonic
development resulting from the imposition of a BSO-
induced oxidized cellular environment is likely the result of
a complex genetic network that is not properly executed
under standard tissue culture conditions.123
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ing the molecular mechanisms of relevant developmental
processes, including embryogenesis. Over the past few
years cDNA microarray studies have revealed the existence
of transcript patterns associated with embryo development
in both angiosperms (Girke et al. 2000; Thibaud-Nissen
et al. 2003; Joosen et al. 2007; Malik et al. 2007) and gym-
nosperms (Stasolla et al. 2003, 2004b). Most importantly,
these studies have revealed the existence of key genes able
to aVect the embryogenic process if their expression level is
experimentally altered (Tahir et al. 2006; Belmonte et al.
2007). Here we use microarray technology to elucidate the
eVect of a BSO-mediated oxidized environment on global
changes of gene expression during the middle and late
phases of Brassica MDE development. We propose that the
morphological and physiological improvements in embryo
quality observed after BSO treatment can be attributed to
underlying transcriptional changes regulating antioxidant
responses, and mechanisms controlling meristem formation
and embryo maturation.
Materials and methods
Brassica napus embryo development and BSO treatments
Induction of embryo development from B. napus cv Topas
DH4079 microspores and applications of BSO were car-
ried out exactly as reported by Belmonte et al. (2006). For
this experiment days in culture were counted after the
imposition of the heat shock treatment. Globular embryos
were treated at day 7 with 0.1 mM BSO (Belmonte et al.
2006). Control and BSO-treated embryos were harvested
at day 7 after the heat shock treatment (at the same time
BSO was added to the culture medium), 14, 21 and 35, fro-
zen in liquid nitrogen and subsequently stored at ¡80°C.
Samples were referred to as stage 0 (day 7) stage 1C, 2C, 3C
(control embryos collected at day 14, 21, and 35, respec-
tively), and stage 1B, 2B, 3B (BSO-treated embryos col-
lected at days 14, 21, and 35). For some of the studies,
embryos were also treated with 0.2 mM GSH (Belmonte
et al. 2006).
Histological analyses and ascorbate metabolism
Structural studies during embryo development were con-
ducted exactly as reported by Yeung (1999). Measure-
ments of endogenous ascorbate and the enzymatic
reactions of ascorbate peroxidase (APX), dehydroascor-
bate reductase (DHAR), glutathione reductase (GR), and
monodehydroascorbate reductase (MDHAR) were carried
out according to Stasolla and Yeung (2001) and Belmonte
et al. (2006).
Microarray development
The B. napus 50-mer oligo array (see supplementary
Table 1 for a complete list of the oligos) was developed by
Agriculture and Agri-Food Canada using the collection of
approximately 150,000 3 and 5 B. napus ESTs derived
from cDNA libraries representing a range of vegetative tis-
sues of the homozygous line DH12075. A custom unigene
set of sequences identiWed from the collection was used for
oligo design with the aim of developing a resource with the
potential to detect diVerential expression between members
of closely related multi-gene families within the polyploid
B. napus genome. A full description of the development of
the set of 15,000 50-mer oligos will be published separately
(Sharpe et al., in preparation). The oligos were synthesized
by Illumina (San Diego) and printed onto epoxide slides
(Corning Inc. Lovell, MA, USA) using a 48-pin GeneMa-
chines arrayer at the University of Alberta Microarray
Facility (Edmonton, AB, Canada) Microarray Facility.
Each one of the 48 sub-arrays were designed with 26
columns £ 25 rows for a total capacity of 31,200 features.
Each of the 15,000 oligos were replicate spotted within
each sub-array. The Stratagene Alien oligo set (La Jolla,
CA, USA) and phosphate buVer blanks were added as con-
trols.
Experimental design
Three biological replicates were collected for each of the
four control samples (stage 0, 1C, 2C, 3C) and the three BSO
treated samples (1B, 2B, 3B). Each replicate sample was
hybridized on the same slide with a common reference
sample comprising equal amounts of ampliWed RNA
derived from one biological replicate of each of the seven
samples. This experimental design provided information on
gene expression during the progression of embryo develop-
ment in control (stage 0, 1C, 2C, 3C) and BSO treatments
(stage 0, 1B, 2B, 3B), i.e. time course comparison, as well as
between time points across treatments (stage 1C vs. 1B,
stage 2C vs. 2B, and stage 3C vs. 3B), i.e. direct comparison.
A swapped-dye experiment (1C vs. common reference) was
also conducted to verify the eVect of the dye on the hybrid-
ization outcome.
Microarray hybridization and scanning
Total RNA was extracted from control and BSO-treated
embryos using a guanidium isothiocyanate method
described by Ouellet et al. (1992). Total RNA (1 g) was
ampliWed, labeled with Xuorescent Cy3 or Cy5 dyes, and
fragmented, using an RNA ampULSe:AmpliWcation and
Labeling kit (Kreatech Biotechnology, Amsterdam, The
Netherlands) following the manufacturer’s instructions.123
258 Planta (2008) 228:255–272The integrity of the ampliWed RNA and the degree of label-
ing was determined using gel electrophoresis and by mea-
suring Cy5 and Cy3 emissions on a Molecular Imager FX
Pro Plus scanner (BioRad, Munich, Germany http://www.
bio-rad.com).
Microarray hybridizations were carried as described
below. After a pre-hybridization treatment in a buVer con-
taining 5£ SSC, 0.1% SDS, and 0.1 mg/ml BSA at 37°C
for 1 h, the slides were washed three times in 0.1£ SSC at
22°C for 5 min and once in water at 22°C for 30 s. The
slides were dried by centrifugation at 1,000£g for 2 min
and stored until hybridization. The slides were then hybrid-
ized using 200 ng of Cy5-labeled target and 400 ng of Cy3-
labeled target added to warm (37°C) hybridization solution
containing 25% formamide, 5£ SSC, 0.1% SDS, and
0.1 mg/ml salmon sperm. Hybridization was carried out for
16 h at 37°C in a hybridization station (Perkin Elmer Hyb-
Array12™, Perkin-Elmer, Foster City, CA, USA). Post-
hybridization washes were performed by immersing the
slides in a solution composed of 2£ SSC, 0.1% SDS for
15 min at 37°C, followed by two washes in 1£ SSC for
2 min at 22°C, and three washes in 0.1£ SSC for 2 min at
22°C. The slides were dried by centrifugation and Xuores-
cence levels of the Cy dyes were determined using a Scan-
Array 3000 laser scanner (Perkin-Elmer) with ScanArray
software version 3.1 (Packard Bioscience).
Data analysis
The microarray data, expressed in log2 ratios, were Wrst
normalized using a Lowess normalization (Cleveland 1979)
and then subjected to the following criteria: (1) the mean
value of any stage was dismissed if more than one of the
three replicates was missing, and (2) in the time course
analysis, a value was dismissed if two or more time points
were missing across the series of control or BSO-treated
embryos. Based on these two criteria 3,023 probes (which
included more than 1,000 blanks) were eliminated from fur-
ther analysis. The remaining probes were analysed with
analysis of variance (ANOVA). An F-probability (P value)
and an least signiWcant diVerence (LSD value) were calcu-
lated for each clone on the array and then adjusted for mul-
tiple comparisons according to the procedure of Benjamini
and Hochberg (1995) to test for signiWcant diVerences
among samples. The adjusted P values were used to verify
if a diVerence observed between stages and treatments was
statistically signiWcant. The LSD was calculated based on
the standard deviation among the replicates and used to
identify patterns of gene expression among elements on the
array that showed signiWcant diVerences among samples. A
Wrst selection was performed by comparing the expression
ratios of signal intensities at diVerent stages or treatments,
and selecting only those probes having an adjusted P
value · 0.05 and an absolute diVerence in expression ratios
higher than the LSD. The stringency of the analysis was
further increased by considering diVerentially expressed
probes as being only those having a diVerence in log2 ratios
between two point comparisons greater than 1.5 in at
least one of the two duplicate spots of the same probe,
with the other spot showing a similar behavior (Pearson
correlation ¸ 0.8). The presented values are therefore
expressed as average signals over the two replicate probes.
To exclude possible dye eVects, all probes exhibiting an
opposite behavior in the swapped-dye experiment were
eliminated from the Wnal analysis.
The normalized log2 ratios of the probes were imported
in GeneMaths (GeneMaths XT (Applied Maths, Sint-
Martens-Latem, Belgium http://www.applied-maths.com/
genemaths/genemaths.htm) and used to perform hierarchi-
cal cluster analysis, cluster analysis by self-organizing maps
(SOMs), and principal component analysis (PCA).
Validation of microarray data and expression analysis
Microarray data were validated by quantitative real-time
(RT)-PCR according to Stasolla et al. (2003) for selected
genes that showed diVerential expression patterns during
embryo development. The relative level of gene expression
was determined with the 2¡CT method (Livak and Sch-
mittgen 2001) using actin (accession number AF111812) as
a reference and the common reference (combined pooled of
the seven sample stages) as the calibrator. The primer
sequences are shown in supplementary Table 2.
BnZWILLE was isolated from MDEs using RACE PCR
based on sequence information obtained from Arabidopsis.
Results
EVects of BSO on the endogenous glutathione pool 
and embryo structure
Applications of BSO in the culture medium shifted the glu-
tathione redox state towards its oxidized form, i.e. GSSG
(Fig. 1). Compared to control embryos, the GSH/
GSH + GSSG ratio declined quickly in BSO-treated
embryos over the course of the culture period, reaching its
minimum value in fully mature stage 3 embryos. A decline
in this ratio during the late phases of embryogenesis was
also observed in vivo (Fig. 1). Structural studies were con-
ducted to investigate the eVects of BSO treatments on
embryo morphology. BSO was added to the embryo culture
medium at day 7 (stage 0), when the MDE culture mainly
comprised early globular-stage embryos (Fig. 2). After a
week (day 14, stage 1) embryos increased in size and the
apical meristem and a pair of cotyledons were visible at the123
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cotyledon-stage embryos had completed their histodiVeren-
tiation program. The shoot apical meristem was fully
formed, but signs of deterioration, as estimated by the
appearance of small intercellular spaces, became visible in
control embryos (Fig. 2). These abnormalities were not
observed in stage 2 BSO-treated embryos (Fig. 2), which
are able to regenerate viable plants at a higher frequency
(46% compared to 33% of control) (Belmonte et al. 2006).
Compared to control embryos, where meristem deteriora-
tion became more pronounced upon prolonged culture (day
35, stage 3) (Fig. 2), the apical pole of BSO-treated
embryos remained intact (Fig. 2). Overall, stage 3 BSO-
treated embryos displayed an improved post-embryonic
growth (76% conversion frequency compared to 11% of
control embryos) (Belmonte et al. 2006).
Transcriptome analysis during embryo development
Transcriptome analysis was conducted to compare mRNA
proWles during the progression of embryo development in
the absence or presence of BSO (time course comparison),
as well as to identify genes that are diVerentially expressed
between treatments at each stage of development (direct
comparison). A custom B. napus oligo microarray com-
posed of 15,000 unique gene-speciWc probes, each of which
was spotted in duplicate, was used for these analyses. The
arrays were hybridized to targets generated from control
and BSO-treated embryos harvested at stage 0, 1, 2, and 3.
Each of the ampliWed targets was then hybridized against a
common reference composed by pooling ampliWed RNA
samples from all stages (see “Material and methods”). The
reliability of the microarray data was conWrmed by moni-
toring the expression level of seven diVerentially expressed
probes using quantitative real-time (RT)-PCR. The expres-
sion ratios of the selected probes using RT-PCR was very
similar to the ratios derived from the microarray experi-
ment and the Pearson correlation coeYcient between the
two data sets was always higher than 0.8 (supplementary
Table 3).
A principal component analysis (PCA) plot was used to
visualize overall diVerences in expression patterns between
the control and BSO-treated samples. As shown in Fig. 3,
the three biological replicates for each stage of develop-
ment and treatment clustered into distinct groups indicating
little variation among replicated samples. Overall diVer-
ences in global transcript levels between treatments, i.e.
control (C) and BSO (B), were apparent after stage 1 and
increased markedly during the following phases of devel-
opment (Fig. 3). These results correlated closely with the
morphological studies showing that major structural diVer-
ences in the apical poles of control and BSO-treated
embryos became apparent at stage 2 and increased at stage
3 when control embryos exhibited extreme cellular deterio-
ration in the meristematic region (Fig. 2).
Time course analysis
Using the ANOVA test statistic (P value) and LSD values,
we identiWed 446 elements (see supplementary Table 4)
which had a signiWcant diVerence in log2 ratio between two
neighboring stages of embryo development greater than 1.5
for at least one of the two duplicated probes, with the other
probe exhibiting a similar behavior (Pearson coeYcient ¸ 0.8).
The number of probes showing diVerential expression
between progressive stages of embryo development in the
absence (control) or presence of BSO is shown in Fig. 4a.
During the transition from stage 0 to stage 1 about 200
probes were diVerentially expressed in both control and
BSO-treated embryos. This number decreased markedly
from stage 1 to stage 2 before increasing again during the
last phases of development, but only in the presence of
BSO. Approximately 250 probes were diVerentially
expressed between stages 2 and 3 in BSO-treated embryos,
compared to less than 75 probes between stages 2 and 3 in
control embryos (Fig. 4a). This divergent expression proWle
during late embryogeny was also visualized using hierar-
chical cluster analysis (compare the signal intensity
between 2C vs. 3C and 2B vs. 3B in Fig. 4b). Self organizing
maps (SOMs) were further generated to identify clusters of
genes showing similar expression proWles during the pro-
gression of embryo development. The most representative
SOMs are shown in Fig. 5. Five SOMs (A–E) included
genes exhibiting an almost identical transcription pattern
during the development of both control and BSO-treated
Fig. 1 Glutathione redox state (GSH/GSH + GSSG) during the diVer-
ent stages (0–3) of Brassica napus microspore-derived embryos cul-
tured in the absence (control) or presence of 0.1 mM BSO. The
glutathione redox state of B. napus seeds containing mid- (MC) and
late cotyledon stage (LC) embryos, as well as mature (M) embryos is
also shown as an inset
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shown in Table 1. The majority of these genes are involved
in basic cellular metabolic processes ranging from nitrogen
metabolism (nitrate reductase, glutamine synthetase, and
aspartate aminotransferase), to lipid metabolism (fatty acid
elongase 1 and several lipid transfer proteins). Of interest is
the large number of photosynthesis-related genes grouped
in SOM C that show a pronounced increase in transcript
levels during the initial phases of embryo development, i.e.
from stage 0 to stage 1 (Fig. 5; Table 1). The remaining
SOMs (F–M) include genes that show diVerential behavior
between treatments. These include an ascorbate peroxidase
and a CLAVATA3/ESR-related 27 gene (SOM f, Fig. 6),
both of which are up-regulated in BSO-treated embryos
during early embryogeny (stage 1), several genes involved
in a variety of developmental (LOB 41, NO APICAL MERI-
STEM) and metabolic (fructose-6-P-phorphotransferase,
glutathione-S-transferase, and aspartate aminotransferase)
processes, which are induced by BSO during middle
embryogeny (stage 2), and other genes up-regulated in
BSO-treated embryos during late embryogeny (stage 3).
Among the latter are several genes encoding transcription
factors (a myb-related protein, Hap5a and a homeodomain
leucine-zipper protein), hormone-regulated proteins (an
Fig. 2 Structural features of 
control and BSO-treated devel-
oping embryos. a Day 7 (stage 0) 
microspore-derived embryo cul-
tures are characterized by the 
presence of globular stage em-
bryos. b Upon further develop-
ment (day 14, stage 1) the 
embryos increase in size and two 
cotyledons emerge from the api-
cal pole of the embryos delineat-
ing the early cotyledonary stage 
of development. Structural 
diVerences between control and 
BSO treatments become visible 
after 21 days (stage 2) in culture, 
especially in the shoot apical 
poles of the embryos. c Small 
intercellular spaces (arrows) ap-
pear in the sub-apical region of 
the shoot apical meristems of 
stage 2 control embryos. d No 
structural abnormalities are visi-
ble in the apical pole of BSO-
treated embryos at stage 2. The 
apical pole is generally dome-
shaped and composed of highly 
cytoplasmic cells. e Cellular 
deterioration continues in the 
shoot apical meristems of stage 3 
control embryos, which, in ex-
treme cases, results in the com-
plete physical separation of the 
meristematic cells. These cells 
also lose their “meristematic 
features” as they enlarge and 
become vacuolated (arrows). 
f A well organized architecture 
is retained in stage 3 embryos 
cultured in the presence of BSO. 
Scale bars a and e (5 m), 
b (2.5 m), c, d and f (2 m)123
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late-embryogeny abundant (LEA) and storage proteins
(SOM j, Fig. 6). A complete list of probes in the SOMs
shown in Fig. 5 is compiled in supplementary Table 5.
Direct comparison analysis
To identify diVerentially expressed probes between control
and BSO-treated embryos at each stage of development, we
used a similar strategy employed in the time course com-
parisons. Selected probes had a log2 ratio between treat-
ments at the same stage of development greater than 1.5 for
at least one of the two duplicated probes, with the other
probe exhibiting a similar behavior (Pearson
coeYcient ¸ 0.8). The stringency of the selection process
was further increased by selecting only probes for which
the log2 ratio average of the two duplicated probes was
greater than 1.5. Based on the above strategies, we com-
piled a list of 334 diVerentially expressed probes (supple-
mentary Table 6). The number of probes that were
diVerentially expressed between treatments increased dur-
ing development reaching a maximum (219) in stage 3
embryos (Fig. 7). To facilitate our analysis we grouped
these probes in categories based on their putative functions.
Representative probes falling in these categories are
shown in Fig. 8. Several probes implicated in antioxidant
responses encode proteins involved in ascorbate and
glutathione metabolism. An ascorbate peroxidase and a
monodehydroascorbate reductase were induced respec-
tively, in the presence of BSO at stage 1 and stage 3.
Several glutathione-S-transferase encoding probes were
induced by BSO at stage 2. Many probes clustered within
the “Development” category were up-regulated in BSO-
treated embryos at stage 2; these included ZWILLE,
AGO1, a putative AGO7, and a LOB 41-encoding protein.
DiVerences between treatments were also observed for
probes encoding hormone-related proteins (among which
are three ABA-responsive probes) and storage/LEA pro-
teins. This latter set of probes was up-regulated in stage
3 embryos cultured in the presence of BSO (Fig. 8).
Fig. 3 PCA plot of gene expression proWles during diVerent stages
(0–3) of Brassica napus MDE development in control (C) and BSO-
treated (B) embryos. Zero 7 day embryos; 1 day 14 embryos, 2 day 21
embryos, 3 day 35 embryos
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(stage 2) and late (stage 3) embryogeny was also observed
for several probes corresponding to genes involved in tran-
scription-translation, signal transduction, methionine and
nucleotide metabolism, and lipid metabolism (Fig. 8).
Ascorbate metabolism in developing embryos
We observed that genes encoding several antioxidant
enzymes were diVerentially expressed between BSO  and
control treatments (Fig. 8). We therefore determined whether
diVerences in glutathione-ascorbate metabolism (Fig. 9a)
could be detected in developing control and BSO-treated
embryos by measuring endogenous ascorbate and glutathione
levels, as well as the activity of several key regulatory
enzymes, namely ascorbate peroxidase (APX), monodehy-
droascorbate reductase (MDHAR), dehydroascorbate reduc-
tase (DHAR), and glutathione reductase (GR). In agreement
with the gene expression studies, the activities of both APX
and MDHAR increased in BSO-treated embryos at stages 1
and 3, respectively. This diVerential regulation was mainly
ascribed to the imposition of the BSO-induced oxidized envi-
ronment, as GSH applications, which switch the glutathione
pool towards a reduced state (Belmonte et al. 2006), had an
opposite eVect. The activities of both APX and MDHAR in
embryos treated with BSO + GSH were comparable to those
measured in control embryos (Fig. 9b). BSO did not induce
any change in the activity of DHAR, as was also observed at
the gene expression level in the microarray experiments. The
activity of another key enzyme, GR, which recycles GSSG to
Fig. 5 Selected self-organizing 
maps (SOMs) showing 
expression proWles of probes 
during diVerent stages of 
development (0–3) in control 
(C) and BSO-treated MDEs. 
The number of probes in each 
self organizing map is 
represented in brackets 0 1 2 3 0 1 2 3
0 1 2 3
a (12) b (24) c (48)
d (14) e (50) f (15)
g (15) h (38) i (12)
j (62) k (10) l (6)
m (28)
0 1 2 3
Control
BSO
0 1 2 3 0 1 2 3
0 1 2 3 0 1 2 3 0 1 2 3
0 1 2 3 0 1 2 3 0 1 2 3
0 1 2 3123
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Addition of GSH to the embryo culture medium increased
the activity of this enzyme.
Compared to the control embryos, the cellular level of
total ascorbate (ASC + DHA + MDHA) was lower at all
stages of development in BSO-treated embryos, especially
at stage 3, where DHA and MDHA became the most pre-
dominant forms within the overall ascorbate pool. Applica-
tion of GSH had opposite eVects to those described for
BSO. The endogenous ascorbate pool in embryos cultured
with BSO + GSH was comparable to that of control
embryos (Fig. 9c).
Cell measurements
Buthionine sulfoximine altered APX activity and the cellu-
lar ascorbate pool, both of which are implicated in cell wall
loosening (reviewed by Potters et al. 2005). We therefore
hypothesized that cell elongation was aVected in BSO-
treated embryos. To test this hypothesis, we measured cor-
tical cells length in stage 3 MDEs and fully mature zygotic
embryos. Compared to control MDEs, the average length of
cortical cells of middle hypocotyl sections was lower in
BSO-treated embryos and zygotic embryos. Applications of
GSH to MDEs increased cell elongation to values above
those observed in control embryos (Fig. 10).
Expression studies of meristem and embryo marker genes
As BSO altered embryo morphology (Fig. 2) and induced
the expression of several genes related to developmental
processes (Fig. 8), we decided to further investigate the role
of this compound on meristem and embryo formation by
conducting additional expression studies on several devel-
opment-related genes that were not represented on the
array. For this purpose we chose two meristem-expressed
and four embryo-expressed marker genes. The two meri-
stem-expressed genes correspond to a B. napus ZWILLE
homolog (BnZWILLE, accession number EU329719) and a
B. napus homolog of the Brassica oleracea SHOOTMERI-
STEMLESS-1 (BroSTM-1) gene. BroSTM-1 has been
shown to be a reliable meristem-speciWc marker gene (Teo
et al. 2004). The four embryo-expressed markers corre-
spond to B. napus LEAFY COTYLEDON1 and 2 (BnLEC1
and BnLEC2) and two WUSCHEL-RELATED HOMEO-
BOX (WOX) genes, BnWOX2 and BnWOX9, all of which
have been shown to be unequivocal MDE markers (Malik
et al. 2007). Expression studies were conducted by quanti-
tative real-time (RT)-PCR using sets of gene speciWc primers
(supplementary Table 2). Of the six genes tested only three;
BroSTM-1, BnZWILLE, and BnLEC1 showed diVerential
expression between control and BSO treatments (Fig. 11).
BSO induced the expression of BroSTM-1 at stage 3,
BnZWILLE at stage 2, and BnLEC1 at stages 2 and 3. These
changes in transcript levels were only due to the BSO-
induced oxidized environment as they were not observed
Table 1 List of selected genes extracted from the self-organizing
maps (SOMs) A–E shown in Fig. 5, exhibiting a similar expression
proWle during development of control and BSO-treated embryos
SOM A
At1g54000.1 Myrosinase-associated protein
At4g34520.1 Fatty acid elongase 1 (FAE)1
At3g10340.1 Phenylalanine ammonia-lyase (putative)
At5g51210.1 Glycine-rich protein/oleosin
At1g62510.1 Lipid transfer protein (LTP)
At1g77760.1 Nitrate reductase 1
At4g09760.2 Choline synthase
SOM B
At3g17390.1 S-adenosylmethionine synthetase
At3g03640.1 Glycosyl hydrolase family 1 protein
At1g03880.1 12S seed storage protein
At4g01610.1 Cathepsin B-like cysteine protease
At4g21990.1 5-adenylsulfate reductase (APR3)/
PAPS reductase homolog
At4g11650.1 Osmotin-like protein (OSM34)
At3g17820.1 Glutamine synthetase (GS1)
At3g10985.1 Wound responsive protein
At1g07600.1 Metallothionein-like protein
SOM C
At2g28950.1 Expansin (EXP6), putative
At4g28250.1 Expansine (EXPB3)
At1g20020.1 Ferredoxin-NADP+ reductase
At4g37870.1 Phosphoenolpyruvate carboxykinase
At1g29930.1 Chlorophyll A-B binding protein 2
At3g08940.2 Chlorophyll A-B binding protein LHCII type 1
At3g61470.1 Chlorophyll A-B binding protein LHCA2
At2g30570.2 Photosystem II reaction center W
At1g61520.1 Chlorophyll A-B binding protein LHCI type 3
At4g21280.1 Oxygen evolving enhancer protein 3
At4g28750.1 Photosystem I reaction center subunit IV
At2g37630.1 myb transcription factor (MYB91)
SOM D
At3g28200.1 Peroxidase
At3g24503.1 Aldehyde dehydrogenase
At3g21560.1 UDP-glucosyltransferase
At4g31990.2 Aspartate aminotransferase
At5g35630.1 Glutamine synthetase (GS2)
At3g21560.1 UDP-glucosyltransferase, putative
SOM E
At4g39330.1 Mannitol dehydrogenase, putative
At3g51600.1 Lipid transfer protein 5 (LTP5)
At5g59320.1 Lipid transfer protein 3 (LTP3)
At5g59310.1 Lipid transfer protein 4 (LPT4)
At1g10370.1 Glutathione-S-transferase123
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(Fig. 11).
Discussion
Due to the diYculty of isolating and manipulating zygotic
embryos, investigations on various aspects of embryo devel-
opment have primarily made use of embryos derived from in
vitro culture systems. The establishment of “healthy” imma-
ture embryos is critical for initiating proper development,
although it does not guarantee the successful completion of
the embryogenic process. Cellular and tissue deterioration
are often observed in culture where they disrupt the architec-
ture of developing MDEs leading to poor post-embryonic
performance and in extreme cases embryo abortion (Yeung
et al. 1996; Belmonte et al. 2006). The fact that these abnor-
mal phenomena are not observed in vivo underlines the
importance of improving culture conditions during the mid-
dle and late phases of embryogenesis as well as the need for
understanding the molecular mechanisms which regulate the
progression from immature to fully mature embryos.
Fig. 6 ProWles of selected 
probes that exhibit diVerential 
expression patterns between 
control and BSO-treated embryo 
development. The probes belong 
to several self-organizing maps 
(SOMs) shown in Fig. 4. 
Expression values (y axis) were 
normalised to those of day 7 em-
bryos (stage 0), which were set 
at 0
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nous balance of GSH and GSSG, plays a key role in a vari-
ety of developmental processes (Tommasi et al. 2001;
Yeung et al. 2005), including embryogenesis (Arrigoni
et al. 1992; Belmonte et al. 2006; Belmonte and Stasolla
2007). As observed in this study (Fig. 1) a shift of the gluta-
thione pool towards its oxidized form, GSSG, occurs in
developing seeds to ensure the proper execution of the
developmental pathway (Arrigoni et al. 1992). The imposi-
tion of an oxidized environment, which can be achieved in
culture through exogenous applications of the GSH-biosyn-
thetic inhibitor BSO (GriYth and Meister 1979) (Fig. 1)
prevents cellular deterioration in the apical poles of the
embryos (Fig. 2), thereby improving their quality. Bel-
monte et al. (2006) described a more “normal” or “zygotic
like” appearance of embryos treated with BSO and a
respective increase in conversion frequency of 28 and 85%
for stages 2 and 3 MDEs, when this compound was added
into the medium. These observations allowed us to dissect
gene expression diVerences in a comparison between the
abnormal structure observed in control embryos and the
enhanced development of BSO-treated embryos. For clarity
we will refer to “early response” as those developmental
events aVected by BSO at stage 1 and “late response” those
aVected by BSO later in culture.
The “early response”
The developmental transition from globular embryos (stage
0) to early cotyledonary embryos (stage 1), characterized
by major histodiVerentiation events required for proper cell
and tissue patterning (Yeung et al. 1996), is accompanied
by major changes in gene expression (more than 200
probes, Fig. 4a). The molecular regulation of these events
does not seem to be greatly aVected by BSO, as only 18
probes were diVerentially expressed between treatments
during this transition phase (Fig. 7). However, among these
probes are several encoding proteins related to develop-
mental processes, including ARGONAUTE 1 (AGO1), a
protein that is closely related to AGO7, and CLAVATA3
ESR-related 27 (CLE 27) (Fig. 8). The ARGONAUTE
family are large proteins characterized by conserved PAZ
and PIWI domains that are thought to be important for pro-
tein–protein interaction (Cerrutti et al. 2000). AGO pro-
teins, in addition to their well characterized role in RNA
interference (reviewed by Carmell et al. 2002), have been
shown to regulate stem cell identity and cell fate decision in
both animal and plant systems (Bohmert et al. 1998; Mous-
sian et al. 1998; Cox et al. 1998; Kataoka et al. 2001).
Genetic analyses suggest that AGO1 is required for both
meristem formation and identity (Lynn et al. 1999; Kidner
and Martienssen 2005), as in ago1 mutant plants the shoot
apical meristem is often replaced by a pin-like organ (Lynn
et al. 1999). AGO1-mediated regulation of the apical meri-
stem may be due to the interaction of this gene within sev-
eral pathways, which include proper accumulation and
localization of SHOOTMERISTEMLESS, speciWcation of
CUPSHAPED COTYLEDONS 1 and 2 boundaries, and
expression of several homeodomain-leucine zipper (HD-
ZIP) family members (Kidner and Martienssen 2005).
Recent work (Nagasaki and Sato 2007) has showed that
mutations in rice SHL4/SHOOT ORGANIZATION2
(SHO2), which encodes an ortholog of Arabidopsis AGO7,
result in abnormal meristem formation during embryogene-
sis. Taken together these results suggest that the BSO-acti-
vation of several ARGONAUTE genes between stage 0 and
stage1 may be required to ensure proper meristem forma-
tion. Another developmentally regulated probe that is
induced by BSO treatments during the early embryogenic
phases encodes a CLE 27 protein. The Arabidopsis genome
contains 31 CLE genes encoding 26 short peptides.
Although some of the CLE genes, have been shown to
unequivocally regulate meristem size (Fletcher et al. 1999;
Fiers et al. 2005), not much is known about the functions of
the other members. Recent work (Ito et al. 2006) suggests
that CLE 27 may play a similar role in meristem develop-
ment.
The “late response”
Unlike the early stages, late stages (2 and 3) control and
BSO-treated embryos are characterized by profound diVer-
ences in gene expression patterns (Fig. 7). Several diVeren-
tially expressed probes falling in this “late response” were
clustered within the categories of “Antioxidant response”,
“Developmental response”, “Hormone-related”, and
Fig. 7 Number of probes which are diVerentially expressed between
the same stage of development (1–3) in control and BSO-treated em-
bryos. Probes up-regulated or down-regulated in BSO embryos com-
pared to their control counterparts are represented by closed and open
bars, respectively
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following sections.
Antioxidant response
Several probes encoding antioxidant-related proteins were
diVerently expressed between treatments at stages 2 and 3
(Fig. 8). Five probes (two of them representing diVerent B.
napus orthologues corresponding to the same Arabidopsis
gene) encoding glutathione-S-transferase (GST) proteins
are up-regulated in stage 2 BSO-treated embryos. GSTs are
homo- or hetero-dimeric proteins involved in detoxiWcation
processes through the conjugation of glutathione to a vari-
ety of substrates including reactive oxygen species. These
Fig. 8 Expression diVerences 
of probes involved in several 
cellular processes between con-
trol and BSO-treated embryos at 
stage 1, 2, and 3 of development. 
Colors indicate probes which are 
either up-regulated (red) or 
down-regulated (green) in BSO 
embryos compared to control. 
The color scale shown in Fig. 4b 
depicts fold changes in the 
expression ratios between sam-
ples. The number in each box 
indicates fold-change values that 
are statistically signiWcant using 
the criteria outlined in “Material 
and methods”. The gene identi-
Wer for the most closely related 
Arabidopsis gene is indicated for 
each B. napus probe
Superoxide dismutase [Cu-Zn]                    At2g29190.1
Catalase 3 (SEN2)                                         At1g26020.1
Glutathione S-transferase, putative            At2g02930.1
Glutathione S-transferase, putative            At1g17170.1
Superoxide dismutase [Mn]                         At3g56350.1
Glutathione S-transferase, putative            At2g29420.1
Glutathione S-transferase, putative            At2g29420.1
L-ascorbate peroxidase (APX1)                   At1g07890.3
Glutathione S-transferase, putative            At2g29430.1
Monodehydroascorbate reductase At3g52880.1
Antioxidant-response
Development
No apical meristem protein                         At5g08790.1
No apical meristem protein                         At5g63790.1
LOB domain protein 41                               At3g02550.1
Zwille At5g43810.1
PAZ-domain, similar to AGO7                   At1g69440.1
Scarecrow-like 11                                         At3g46600.2
No apical meristem (NAM)                          At2g17040.1
AGO1                                                            At1g48410.2
Clavata3/ESR-related 27                             At3g25905.1
Hormone-related
Auxin-responsive (GH3)                              At1g23160.1
Gibberellin-responsive (RGA1)                   At2g01570.1
Auxin-responsive                                          At3g16500.1
Gibberellin-regulated (GASA3)                  At4g09600.1
ABA-responsive (HVA22b)                         At5g62490.1
ABA-responsive                                            At3g02480.1
ABA-responsive                                            At3g02480.1
Auxin-responsive factor (ARF7)                 At5g20730.1
Storage-LEA
12S seed storage                                            At4g28520.1
LEA, group 1                                                 At2g35300.1
12S seed storage (CRA1)                              At5g44120.3
LEA                                                             At3g53040.1
LEA                                                             At1g04560.1
LEA-domain containing                              At4g21020.1
LEA (putative)                                              At5g06760.1
LEA, group 1                                                At5g06760.1
LEA (ECP63)                                                At2g36640.1
LEA, putative                                                At1g01470.1
LEA-domain containing                               At5g44310.1
LEA-domain containing                               At3g17520.1
LEA                                                             At3g15670.1
1             2            3
Embryonic stages
1.71123
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types, although they are preferentially present during inten-
sive active growth. In animal systems GSTs are expressed
especially during embryonic and fetal growth where they
support normal growth and development by reducing the
levels of toxic organic hydroperoxides (Raijmakers et al.
2001). A similar role may also be exercised during plant
embryo development, as this ubiquitous group of proteins
has been shown to increase during embryo development in
a variety of culture systems (Vrinten et al. 1999; Galland
et al. 2001; Maraschin et al. 2006). BSO-mediated up-regu-
lation of several GSTs may therefore be required for pro-
tecting the developing embryos against stress conditions,
thereby ensuring successful growth and normal develop-
ment.
Since glutathione metabolism is closely linked and
dependent upon ascorbate synthesis and utilization in
MDEs, it is not surprising that BSO aVects several key
ascorbate enzymes, including ascorbate peroxidase (APX),
and monodehydroascorbate reductase (MDHAR). Ascor-
bate peroxidase is a well characterized ASC-consuming
enzyme (De Gara and Tommasi 1999). The higher APX
activity in BSO-treated embryos during early development
may have a double function; it may have a major role in
decreasing the toxic levels of H2O2 generated during active
embryonic growth, as the transcript levels of a catalase
probe is lower in these embryos, and may also maintain cell
wall plasticity by reducing the pool of H2O2 utilized by cell
wall peroxidases in cross-linking cell wall polymers (De
Gara et al. 1996). A reduction in cell wall-linking peroxi-
dase activity may be beneWcial for embryo development
and shoot meristem formation (Stasolla and Yeung 2006).
The increased APX activity observed in BSO-treated
embryos can be reversed by applications of GSH, suggesting
Fig. 8 continued Transcription-translation
Signal transduction
RNA polymerase sigma subunit                  At1g08540.1
WRKY transcription factor                         At4g31800.1
myb transcription factor                              At1g14600.1
Translation initiation factor SUI1               At5g54940.1
bZIP transcription factor                             At1g42990.1
myb transcription factor                              At5g23840.1 
TCP type transcription factor                     At1g18390.1
CBL interacting protein kinase 6                   At4g30960.1
EF-hand Ca++ binding protein, putative        At2g46600.1
Vacuolar Ca++ binding protein, putative       At1g62480.1
Calmodulin-2/3/5 (CAM3)                               At3g56800.1
Calmodulin-related proten At3g50770.1
14-3-3 proten GF14                                          At3g02520.1
Rho-GTPase-activating protein, putative      At4g35750.1
Protein kinase C inhibitor, putative               At3g56490.1
Dephospho-CoA kinase At2g27490.2
Protein kinase-like, putative                           At1g78530.1
Ras-related GTP-binding protein                  At5g20020.1
Methionine-nucleotide metabolism
S-adenosylmethionine synthetase At3g17390.1              
S-adenosylmethionine decarboxylase At3g02470.1       
UDP-glucoronosyl/UDP-glucosyl transferase At4g15280.1
UDP-glucorenosyl/UDP-glucosyl transferase At2g36800.1
UDP-glucoronosyl/UDP-glucosyl transferase At4g34138.1
ADP-ribosylation factor, putative                    At1g70490.1
5’adenylsulfate reductase (APR3)                    At4g21990.1
Urea amidolyase At3g04560.1
Lipid-associated protein                                  At4g39730.1 
Lipid metabolism
Lipoxygenase (LOX2)                                      At3g45141.0       
Acyl desaturase At2g43710.1
MD-2 lipid-recognition domain protein          At3g44100.1
Lipase (class 3)                                                At4g00500.1
Fatty acid elongase 1                                         At4g34520.1
Omega-3 fatty acid desaturase At2g29980.1
1              2             3
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268 Planta (2008) 228:255–272Fig. 9 a Schematic diagram of 
the ascorbate-glutathione sys-
tem. ASC reduced ascorbate, 
MDHA monodehydroascorbate, 
DHA dehydroascorbate, GSH re-
duced glutathione, GSSG oxi-
dized glutathione, H2O water, 
H2O2 hydrogen peroxide, 
NADP+ nicotinamide adenine 
dinucleotide phosphate oxidized 
form; NADPH, nicotinamide 
adenine dinucleotide phosphate 
reduced form, MDHAR monode-
hydroascorbate reductase, APX 
ascorbate peroxidase, DHAR de-
hydroascorbate reductase, GR 
glutathione reductase. b Enzy-
matic activity of APX, MDHAR, 
DHAR, and GR during the diVer-
ent stages (0–3) of untreated em-
bryo and embryos treated with 
BSO, GSH, and BSO + GSH. 
Values § SE represent the mean 
of 3 or more independent exper-
iments. Stars above each bar 
indicate values which are signiW-
cantly diVerent from control val-
ues (P · 0.05) at the same 
sampling time. c Endogenous 
ascorbate pool measured in 
developing embryos subjected to 
the treatments indicated in (b)
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lar glutathione redox-state. High levels of APX during the
early development of BSO-treated embryos also reduce the
total cellular ascorbate pool. This would explain why appli-
cations of BSO reduce the overall size of MDEs (Belmonte
et al. 2006). In agreement with previous studies, which
show a correlation between ascorbate levels and cell divi-
sion and elongation (reviewed by Potters et al. 2005), low
ascorbate levels in BSO-treated MDEs also correlate with a
reduction in cell elongation, although no eVect on cell divi-
sion was observed (data not shown).
During the late phases of development the BSO-induced
oxidized glutathione environment aVects the transcription
and activity of MDHAR, as well as the composition of the
total ascorbate pool, which becomes enriched with the oxi-
dized forms, i.e. DHA and MDHA. The high activity of the
ASC recycling enzyme MDHAR and the increasing levels
of MDHA and DHA in BSO-treated embryos may be a
strategy to eYciently regenerate ASC at the onset of germi-
nation, prior to the complete reactivation of the de novo
ASC biosynthetic pathway. These metabolic alterations,
documented during normal embryonic growth in vivo and
in vitro (De Gara et al. 1997; Stasolla and Yeung 2001), are
not observed in control embryos. The potential to quickly
regenerate ASC from MDHA in the presence of an oxi-
dized glutathione environment may explain the improved
conversion frequency of BSO-treated embryos (Belmonte
et al. 2006). High levels of ASC during the early phases of
germination are required for meristem reactivation and the
successful continuation of post-embryonic development in
vitro (Stasolla and Yeung 2006).
Developmental response
Many probes encoding genes directing developmental pro-
cesses were up-regulated in BSO-treated embryos at stage 2
(Fig. 8). These included those participating in the “early
response”, such as AGO1 and CLE 27, as well as ZWILLE.
Both the microarray and RT-PCR data showed that
ZWILLE is up-regulated at stage 2 in BSO-treated embryos
(Figs. 8, 11). In Arabidopsis ZWILLE plays a key role in
maintaining an undiVerentiated group of cells in the shoot
meristem during late embryogenesis (Moussian et al.
1998). Mature zll embryos have disrupted shoot apical mer-
istems in which the stem cells diVerentiate and fail to gen-
erate new organs during post-embryonic growth (Moussian
Fig. 10 Cortical cell elongation in zygotic embryos, untreated (con-
trol) microspore-derived embryos and MDEs treated with BSO, GSH,
and BSO + GSH. Cortical cells in the middle section of the hypocotyl
were measured at stage 3 (and fully mature zygotic embryos).
Values § SE represent the mean of three independent experiments.
Stars above each bar indicate values that are signiWcantly diVerent
from control values (P · 0.05) at the same sampling time
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Fig. 11 Expression proWles of B. napus STM–1, ZWILLE, and LEC1
during the four stages of development (0–3) in untreated embryos and
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expression pattern of SHOOTMERISTEMLESS (STM),
which is also involved in the maintenance of the apical pole
(Long et al. 1996). Our RT-PCR data indicate that expres-
sion of an STM homolog increased in BSO-treated embryos
at stages 3. These changes in expression patterns, due to the
BSO-induced oxidized cellular environment as they are
generally reversed in embryos treated with GSH, suggest
that BSO improves the formation and maintenance of the
apical poles through the activation of meristem-speciWc
genes. Reduced or misexpression of these genes in the api-
cal pole of control embryos may contribute to the structural
deterioration observed during late embryogeny leading to
stem cell diVerentiation.
We further investigated whether BSO controls other
general embryonic processes by conducting RT-PCR anal-
yses on a set of “embryo marker” genes identiWed by Malik
et al. (2007). Among the genes tested, only Bn LEC1 is
aVected by BSO during stages 2 and 3 (Fig. 11). LEC1 is a
transcription factor involved in several developmental pro-
cesses ranging from cotyledon identity speciWcation and
proper completion of embryo growth (Lotan et al. 1998). Its
over-expression in vegetative tissue has been shown to
induce somatic embryogenesis (Lotan et al. 1998). West
et al. (1994) showed that lec1 embryos are intolerant to des-
iccation, lack protein bodies in their cotyledons, and initiate
post-germinative development prematurely. Together,
these results suggest that the up-regulation of LEC1 in
BSO-treated embryos contributes to the acquisition of
maturity and improved post-embryonic performance.
Hormone-related mechanisms
Buthionine sulfoximine treatments alter the expression pat-
terns of several hormone-responses/regulated probes
(Fig. 8). Of interest are three probes encoding two ABA-
responsive proteins that are up-regulated by BSO at stage 3.
This observation is in line with previous studies (Belmonte
et al. 2006) showing that BSO alters ABA synthesis and
catabolism during embryo development. We suggested that
the beneWcial eVect of BSO during embryo growth was
possibly due to an increased level of ABA, which plays a
key role during in vivo and in vitro embryo maturation
(reviewed by Kermode 1995; Thorpe and Stasolla 2001).
Application of ABA in the MDE culture mimicked the
eVects of BSO, whereas a reduction of cellular ABA
through Xuoridone addition had a negative eVect (Belmonte
et al. 2006).
Ethylene is a gaseous plant growth regulator which often
accumulates in culture under stress conditions (Gaspar
et al. 1996), causing pronounced structural abnormalities
including the formation of intracellular air-spaces observed
in control MDEs (Fig. 2). Synthesis of ethylene is initiated
by conversion of S-adenosylmethionine into 1-aminocyclo-
propane-1-carboxylate (ACC) which is subsequently con-
verted to ethylene by the enzyme ACC oxidase (reviewed
by Gaspar et al. 1996). In BSO-treated embryos a probe
encoding S-adenosylmethionine synthase, the enzyme gen-
erating S-adenosylmethionine from methionine, is down-
regulated at stage 2 (Fig. 8). Down-regulation of this
enzyme may reduce ethylene production and accumulation
in BSO-treated embryos, thereby preventing cellular deteri-
oration in the shoot meristem. In support of this observa-
tion, spruce somatic embryos treated with BSO produce
less ethylene (Belmonte et al. 2005).
Seed storage and LEA proteins
Storage product and late embryo-aboundant (LEA) protein
deposition during in vitro embryo development is a highly
orchestrated process which is required for successful post-
embryonic performance (Yeung 1995). While storage prod-
ucts are needed as an energy source for the germinating
embryo, the highly hydrophilic LEA proteins protect many
cellular components from the severe dehydration accompa-
nying the later phases of seed/zygotic embryo development
(reviewed by Kermode 1995). The up-regulation of many
probes encoding storage products and LEAs during the late
phases of development of BSO-treated embryos (Fig. 8)
indicates a more complete “maturation state” reached by
embryos cultured in an oxidized glutathione redox environ-
ment. These events, lacking in control embryos, suggest
that under control conditions stage 3 embryos are morpho-
logically ready to undergo post-embryonic growth but are
not physiologically prepared to do so. This notion is also
conWrmed by Belmonte et al. (2006) who showed that com-
pared to their control counterparts, BSO-treated embryos
have a “zygotic-like” storage deposition pattern as they
preferentially accumulate lipids and proteins, and to a lesser
extent starch. The increased accumulation of storage and
LEA proteins observed in the presence of BSO may be the
result of transcriptional or post-translational events. BSO
may promote transcription of these proteins by increasing
the synthesis of ABA (Belmonte et al. 2006), as shown by
Kermode (1995). Alternatively, the BSO-induced oxidized
glutathione environment may stimulate post-translational
mechanisms which facilitate folding and assembling of
newly synthesized storage proteins, as suggested by De
Gara et al. (2003). Increased accumulation of LEAs and
storage products would improve the post-embryonic perfor-
mance of the embryos.
In conclusion, the imposition of an oxidized environ-
ment, eVected by BSO applications is beneWcial for micro-
spore-derived embryogenesis. Compared to their control
counterparts, BSO-treated embryos show improvements in
the structure of the apical meristems, as well as major123
Planta (2008) 228:255–272 271changes in transcript accumulation patterns. Many genes
involved in a variety of functions, such as antioxidant
response and developmental processes, are diVerentially
expressed in the presence of BSO. Besides elucidating the
eVects of this beneWcial compound during embryogenesis,
this work has important implications for the identiWcation
of target genes which can be used to improve embryo pro-
duction and quality via genetic engineering.
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